Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b-Reference-Cited by-同舟云学术

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b

Published:2011-02-25 Issue:5 Volume:83 Page:871-878
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Sakamoto Naoya,Nakagawa Mina,Tanaka Yasuhito,Sekine-Osajima Yuko,Ueyama Mayumi,Kurosaki Masayuki,Nishida Nao,Tamori Akihiro,Yuki Nishimura-Sakurai,Itsui Yasuhiro,Azuma Seishin,Kakinuma Sei,Hige Shuhei,Itoh Yoshito,Tanaka Eiji,Hiasa Yoichi,Izumi Namiki,Tokunaga Katsushi,Mizokami Masashi,Watanabe Mamoru,

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.22038/fullpdf

Reference26 articles.

1. Epidemiology of hepatitis C;Alter;Hepatology,1997

2. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo;Ank;J Virol,2006

3. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C;Fellay;Nature,2010

4. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;Ge;Nature,2009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Interleukin 28B Polymorphisms in Response to Interferon Based Therapy for Hepatitis C Virus Clearance;Current Drug Metabolism;2018-05-08

2. Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study;Hepatology Research;2017-08-10

3. Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C;Journal of Gastroenterology;2016-01-14

4. Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C;Hepatitis C Virus II;2016

5. PharmGKB summary;Pharmacogenetics and Genomics;2015-09